117 related articles for article (PubMed ID: 32283955)
1. An assessment of the protective effect of gonadotropin-releasing hormone agonist and antagonist on bleomycin-induced ovarian toxicity in rats.
Atakul T; Tayyar AT; Turan ÖD; Çelik SY; Yılmaz M; Küçük M; Yüksel H; Demirci B
Gynecol Endocrinol; 2021 Jan; 37(1):46-50. PubMed ID: 32283955
[TBL] [Abstract][Full Text] [Related]
2. Combination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.
Li X; Kang X; Deng Q; Cai J; Wang Z
Reprod Biol Endocrinol; 2013 Mar; 11():16. PubMed ID: 23452939
[TBL] [Abstract][Full Text] [Related]
3. Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist.
Dong M; Huang L; Wang W; Du M; He Z; Mo Y; Yang D
Pharmazie; 2011 Jun; 66(6):436-9. PubMed ID: 21699083
[TBL] [Abstract][Full Text] [Related]
4. [Protective effect of GnRH analogues on the reproductive capacity of women with neoplasia or autoimmune disease who require chemotherapy. Final results of a phase ii clinical trial].
Gris-Martínez JM; Trillo-Urrutia L; Gómez-Cabeza JJ; Encabo-Duró G
Med Clin (Barc); 2016 Feb; 146(3):97-103. PubMed ID: 26194532
[TBL] [Abstract][Full Text] [Related]
5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
6. The GnRH antagonist reduces chemotherapy-induced ovarian damage in rats by suppressing the apoptosis.
Huang YH; Zhao XJ; Zhang QH; Xin XY
Gynecol Oncol; 2009 Feb; 112(2):409-14. PubMed ID: 19038435
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
[TBL] [Abstract][Full Text] [Related]
8. Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment.
Roulier R; Chabert-Orsini V; Sitri MC; Barry B; Terriou P
Reprod Biomed Online; 2003 Sep; 7(2):185-9. PubMed ID: 14567887
[TBL] [Abstract][Full Text] [Related]
9. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H
Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254
[TBL] [Abstract][Full Text] [Related]
10. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
Gründker C; Emons G
Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
[TBL] [Abstract][Full Text] [Related]
11. Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.
Roth C; Schricker M; Lakomek M; Strege A; Heiden I; Luft H; Munzel U; Wuttke W; Jarry H
J Endocrinol; 2001 May; 169(2):361-71. PubMed ID: 11312152
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
Roth CL; Brendel L; Rückert C; Hartmann K
Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
[TBL] [Abstract][Full Text] [Related]
13. Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist.
Mo Y; Peng P; Zhou R; He Z; Huang L; Yang D
Reprod Sci; 2010 Jan; 17(1):68-77. PubMed ID: 19861704
[TBL] [Abstract][Full Text] [Related]
14. Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
Ozcelik B; Turkyilmaz C; Ozgun MT; Serin IS; Batukan C; Ozdamar S; Ozturk A
Fertil Steril; 2010 Mar; 93(5):1609-14. PubMed ID: 19339002
[TBL] [Abstract][Full Text] [Related]
15. A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol.
Loutradis D; Stefanidis K; Drakakis P; Milingos S; Antsaklis A; Michalas S
Fertil Steril; 2004 Nov; 82(5):1446-8. PubMed ID: 15533377
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-Müllerian hormone and histological analysis in a rat model using cisplatin.
Tas M; Oner G; Ulug P; Yavuz A; Ozcelik B
Arch Med Sci; 2023; 19(2):448-451. PubMed ID: 37034528
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.
Gründker C; Schlotawa L; Viereck V; Eicke N; Horst A; Kairies B; Emons G
Eur J Endocrinol; 2004 Jul; 151(1):141-9. PubMed ID: 15248835
[TBL] [Abstract][Full Text] [Related]
18. A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.
Park I; Lee S; Ryu KJ; Min KJ; Hong JH; Song JY; Lee JK; Lee NW
J Obstet Gynaecol; 2017 Aug; 37(6):783-789. PubMed ID: 28502234
[TBL] [Abstract][Full Text] [Related]
19. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
[TBL] [Abstract][Full Text] [Related]
20. GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells.
Khalaf M; Mittre H; Levallet J; Hanoux V; Denoual C; Herlicoviez M; Bonnamy PJ; Benhaim A
Reprod Biomed Online; 2010 Jul; 21(1):56-65. PubMed ID: 20457540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
